150 related articles for article (PubMed ID: 11939270)
1. Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.
Tezuka K; Nakayama H; Honda K; Suzumiya J; Oshima K; Kitoh T; Ishii E
Int J Hematol; 2002 Feb; 75(2):201-6. PubMed ID: 11939270
[TBL] [Abstract][Full Text] [Related]
2. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
[TBL] [Abstract][Full Text] [Related]
3. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
[TBL] [Abstract][Full Text] [Related]
4. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
5. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
[TBL] [Abstract][Full Text] [Related]
6. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
[TBL] [Abstract][Full Text] [Related]
7. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
[TBL] [Abstract][Full Text] [Related]
8. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
9. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
10. An infant with precursor natural killer (NK) cell leukemia successfully treated with an unrelated cord blood transplantation.
Suminoe A; Matsuzaki A; Takada H; Hattori H; Furuno K; Takemoto M; Maki H; Kanaya N; Ohnuma K; Nishihira H; Hara T
Leuk Lymphoma; 2000 Nov; 39(5-6):641-6. PubMed ID: 11342348
[TBL] [Abstract][Full Text] [Related]
11. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
Hashimoto S; Toba K; Aoki S; Tsuchiyama J; Tsukada N; Takahashi H; Takahashi M; Aizawa Y
Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
13. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
14. [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement].
Tomita N; Fujita H; Koharazawa H; Maruta A; Kodama F; Yamamoto T; Kobayashi S; Okubo T
Rinsho Ketsueki; 1997 Feb; 38(2):135-41. PubMed ID: 9059068
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia with mediastinal myeloid sarcoma refractory to acute myeloid leukemia therapy but responsive to L-asparaginase.
Takahashi H; Koh K; Kato M; Kishimoto H; Oguma E; Hanada R
Int J Hematol; 2012 Jul; 96(1):136-40. PubMed ID: 22644614
[TBL] [Abstract][Full Text] [Related]
16. L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation.
Nagafuji K; Fujisaki T; Arima F; Ohshima K
Int J Hematol; 2001 Dec; 74(4):447-50. PubMed ID: 11794702
[TBL] [Abstract][Full Text] [Related]
17. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Giralt S; Estey E; Albitar M; van Besien K; Rondón G; Anderlini P; O'Brien S; Khouri I; Gajewski J; Mehra R; Claxton D; Andersson B; Beran M; Przepiorka D; Koller C; Kornblau S; Kørbling M; Keating M; Kantarjian H; Champlin R
Blood; 1997 Jun; 89(12):4531-6. PubMed ID: 9192777
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma.
Matsumoto Y; Nomura K; Kanda-Akano Y; Fujita Y; Nakao M; Ueda K; Horiike S; Yokota S; Kusuzaki K; Kitoh T; Watanabe A; Taniwaki M
Leuk Lymphoma; 2003 May; 44(5):879-82. PubMed ID: 12802930
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
[TBL] [Abstract][Full Text] [Related]
20. High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Czerw T; Labopin M; Schmid C; Cornelissen JJ; Chevallier P; Blaise D; Kuball J; Vigouroux S; Garban F; Lioure B; Fegueux N; Clement L; Sandstedt A; Maertens J; Guillerm G; Bordessoule D; Mohty M; Nagler A
Oncotarget; 2016 May; 7(19):27255-66. PubMed ID: 27036034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
